Aimmune Therapeutics Inc (NASDAQ:AIMT)

34.35
Delayed Data
As of Sep 29
 +0.025 / +0.07%
Today’s Change
10.09
Today|||52-Week Range
37.00
+2.63%
Year-to-Date

Today’s Trading

Previous close34.33
Today’s open34.33
Day’s range34.32 - 34.41
Volume801,037
Average volume (3 months)1,837,736
Market cap$2.2B
Data as of 4:00pm ET, 09/29/2020

Growth & Valuation

Earnings growth (last year)-8.20%
Earnings growth (this year)-7.30%
Earnings growth (next 5 years)-66.46%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book21.05

Competitors

----
OPKOPKO Health Inc+0.25+7.86%
APLSApellis Pharmaceutic...-0.97-3.25%
AGIOAgios Pharmaceutical...-0.85-2.41%
Data as of 6:31pm ET, 09/29/2020

Financials

Next reporting dateNovember 4, 2020
EPS forecast (this quarter)-$0.97
Annual revenue (last year)$0.00
Annual profit (last year)-$248.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Brisbane, California

Forecasts